Study to Evaluate the Effect of Eleclazine on QT, Safety, and Tolerability in Participants With Long QT2 Syndrome
Clinical trial NCT02365506 · COMPLETED
Trial details
- NCT number
- NCT02365506
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-20
- Primary completion
- 2016-05-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.